3,4′,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling

Antiviral Research

Volumn 63, Issue 2, 2004, Pages 85-95

  Evers, David L ^a   Wang, Xin ^a   Huong, Shu Mei ^a   Huang, David Y ^b   Huang, Eng Shang ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cytomegalovirus; Epidermal growth factor receptor; Resveratrol

Indexed keywords

1,2 BIS(PYRIDYL)ETHYLENE; 1,2 DIBROMO 1,2 DIPHENYLETHANE; 1,2 DIPHENYLETHYLENEDIAMINE; 1,4 DIPHENYL 1,3 BUTADIENE; BENZENE DERIVATIVE; DIETHYLSTILBESTROL; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ETHYLENE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; RESVERATROL; STILBENE; STILBENE DERIVATIVE; TRANS STILBENE OXIDE; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRUS PROTEIN; ANTIVIRUS AGENT; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DNA REPLICATION; EMBRYO CELL; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IC 50; IMMUNOPRECIPITATION; INCUBATION TIME; LUNG FIBROBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TITRIMETRY; TRANSCRIPTION INITIATION; VIRUS CELL TRANSFORMATION; VIRUS REPLICATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECT; FIBROBLAST; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PROTEIN BINDING; TIME; VIROLOGY; VIRUS CULTURE;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIVIRAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; CYTOMEGALOVIRUS; DNA REPLICATION; DNA, VIRAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FIBROBLASTS; HUMANS; NF-KAPPA B; PLAQUE ASSAY; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; STILBENES; TIME FACTORS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 4043184104     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.03.002     Document Type: Article

References (60)

1. Albrecht T., Boldogh I., Fons M., AbuBakar S., Deng C.Z. Cell activation signals and the pathogenesis of human cytomegalovirus. Intervirology. 3:1990;68-75
2. Andreoni K.A., Wang X., Huong S.M., Huang E.-S. Human cytomegalovirus hyperimmune globulin not only neutralizes HCMV infectivity, but also inhibits HCMV-induced intracellular NF-κB, Sp1, and PI3-K signaling pathways. J. Med. Virol. 67:2002;33-40
3. Arichi H., Kimura Y., Okuda H., Baba K., Kozawa M., Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chem. Pharm. Bull. 30:1982;1766-1770
4. Atreides, S.-P.A., Wilkins, C., Ekworomadu, C.O., Docherty, J.J., Dix, R.D., 2002. Does resveratrol exhibit antiviral properties against human cytomegalovirus replication? Invest. Ophthalmol. Vis. Sci. 43, E-Abstract 4325.
5. Baldanti F., Gerna G. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact. J. Antimicrob. Chemother. 52:2003;324-330
6. Balfour H.H. Cytomegalovirus: the troll of transplantation. Arch. Intern. Med. 139:1979;279-280
7. Berk T., Gordon S.J., Choi H.Y., Cooper H.S. Cytomegalovirus infection of the colon: a possible role in the exacerbations of inflammatory bowel disease. J. Gastroenterol. 80:1985;355-360
8. Boldogh I., AbuBakar S., Albrecht T. Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection. Science. 247:1990;561-564
9. Chen N., Ma W.-Y., She Q.-B., Wu E., Liu G., Bode A.M., Dong Z. Transactivation of the epidermal growth factor receptor is involved in 12-O-tetradecanoylphorbol-13-acetate-induced signal transduction. J. Biol. Chem. 276:2001;46722-46728
10. Cherrington J.M., Mocarski E.S. Human cytomegalovirus IE1 transactivates the α promoter-enhancer via an 18-base-pair repeat element. J. Virol. 63:1989;1435-1440
11. Culpitt S.V., Rogers D.F., Fenwick P.S., Shah P., De Matos C., Russell R.E., Barnes P.J., Donnelly L.E. Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax. 58:2003;942-946
12. Docherty J.J., Fu M.M., Stiffler B.S., Limperos R.J., Pokabla C.M., DeLucia A.L. Resveratrol inhibition of herpes simplex virus replication. Antiviral Res. 43:1999;145-155
13. Docherty J.J., Smith J.S., Fu M.M., Booth T. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. Antiviral Res. 61:2004;19-26
14. Evers D.L., Breitenbach J.M., Borysko K.Z., Townsend L.B., Drach J.C. Inhibition of cyclin-dependent kinase 1 by purines and pyrrolo[2,3-d]pyrimidines does not correlate with antiviral activity. Antimicrob. Agents Chemother. 46:2002;2470-2476
15. Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421:1998;277-279
16. Frankel E.N., Waterhouse A.L., Kinsella J.E. Inhibition of human LDL oxidation by resveratrol. Lancet. 341:1993;1103-1104
17. Griffiths P.D. The treatment of cytomegalovirus infection. J. Antimicrob. Chemother. 49:2002;243-253
18. He Y.S., Xu L., Huang E.-S. Characterization of human cytomegalovirus UL84 early gene and identification of its putative protein product. J. Virol. 66:1992;1098-1108
19. Heredia A., Davis C., Redfield R. Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J. Acquir. Immune Defic. Syndr. 25:2000;246-255
20. Hippenmeyer P.J., Dilworth V.M. A rapid assay for determination of antiviral activity against human cytomegalovirus. Antiviral Res. 32:1996;35-42
21. Holmes-McNary M., Baldwin A.S. Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IκB kinase. Cancer Res. 60:2000;3477-3483
22. Huang E.-S. Human cytomegalovirus. III. Virus-induced DNA polymerase. J. Virol. 16:1975a;298-310
23. Huang E.-S. Human cytomegalovirus IV. Specific inhibition of virus induced DNA polymerase activity and viral DNA replication by phosphonoacetic acid. J. Virol. 16:1975b;1560-1565
24. Huang, E.-S., Kowalik, T.F., 1993. The pathogenicity of human cytomegalovirus: an overview. In: Becker, Y., Darai, G., Huang, E.-S. (Eds.), Molecular Aspects of Human Cytomegalovirus. Springer-Verlag, Berlin, pp. 1-45.
25. Huang E.-S., Chen S.T., Pagano J.S. Human cytomegalovirus. I. Purification and characterization of viral DNA. J. Virol. 12:1973;1473-1481
26. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220
27. Johnson R.A., Huong S.-M., Huang E.-S. Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole on HCMV DNA replication and permissive infection. Antiviral Res. 41:1999;101-111
28. Johnson R.A., Wang X., Ma X.L., Huong S.-M., Huang E.-S. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 75:2001;6022-6032
29. Juan M.E., Vinardell M.P., Planas J.M. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 132:2002;257-260
30. Kowalik T.F., Yurochko A.D., Rinehart C.A., Lee C.Y., Huang E.-S. Productive infection of human endometrial stromal cells by human cytomegalovirus. Virology. 202:1994;247-257
31. Kowalik T.F., Wing B., Haskill J.S., Azizkhan J.C., Baldwin A.S. Jr., Huang E.-S. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1107-1111
32. Krueger R.F., Mayer G.D. Tilorone hydrochloride: mode of action. Science. 169:1970;1214-1215
33. LaBarthe D., Adam E., Noller K.L., O'Brien P.C., Robboy S., Tilley B.C., et al. Design and preliminary observation of the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. Obstet. Gynecol. 51:1978;453-458
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685
35. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164:2000;6509-6519
36. Mar E.C., Cheng Y.C., Huang E.-S. Effect of 9-(1,3-dihydroxy-2- propoxymethyl)guanine on human cytomegalovirus replication in vitro. Antimicrob. Agents Chemother. 24:1983;518-521
37. Mar E.C., Chiou J.F., Cheng Y.C., Huang E.-S. Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2- propoxymethyl)guanine. J. Virol. 53:1985;776-780
38. Matsuoka A., Takeshita K., Furuta A., Ozaki M., Fukuhara K., Miyata N. The 4′-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol. Mutat. Res. 26:2002;29-35
39. Mocarski, E.S., Tan Courcelle, C., 2001. Cytomegaloviruses and their replication. In: Knipe, D.M., Howley P.M. (Eds.), Fields Virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, pp. 2629-2673.
40. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J. 17:2003;1975-1985
41. Plotkin S.A. Vaccination against cytomegalovirus, the changeling demon. Pediatr. Infect. Dis. J. 18:1999;313-326
42. She Q.B., Ma W.Y., Wang M., Kaji A., Ho C.T., Dong Z. Inhibition of cell transformation by resveratrol and its derivatives: differential effects and mechanisms involved. Oncogene. 22:2003;2143-2150
43. Slobbe-van Drunen M.E., Vossen R.C., Couwenberg F.M., Hulsbosch M.M., Heemskerk J.W., van Dam-Mieras M.C., Bruggeman C.A. Activation of protein kinase C enhances the infection of endothelial cells by human cytomegalovirus. Virus Res. 48:1997;207-213
44. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30:1997;91-113
45. Spaete R.R., Mocarski E.S. Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7213-7217
46. Speir E., Yu Z.-X., Ferrans V.J., Huang E.-S., Epstein S.E. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res. 83:1998;210-216
47. Speir E., Shibutani T., Yu Z.-X., Ferrans V.J., Epstein S.E. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ. Res. 79:1996;1143-1152
48. Speir E., Modali R., Huang E.-S., Leon M.B., Shawl F., Finkel T., Epstein S.E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 265:1994;391-394
49. St. Leger A.S., Cochrane A.L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1:1979;1017-1020
50. Stewart J.R., Ward N.E., Ioannides C.G., O'Brian C.A. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. Biochemistry. 38:1999;13244-13251
51. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273:1998;21875-21882
52. Sun N.J., Woo S.H., Cassady J.M., Snapka R.M. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Nat. Prod. 61:1998;362-366
53. Tanaka J., Iida H., Sato H., Hatano M. Inhibitors of prostaglandin synthesis inhibit growth of human cytomegalovirus and reactivation of latent virus in a productively and latently infected human cell line. Virology. 163:1988;205-208
54. Wang X., Huong S.-M., Chiu M.L., Raub-Traab N., Huang E.-S. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature. 424:2003;456-461
55. Wing B.A., Lee G.Y.C., Huang E.-S. Human cytomegalovirus UL94 open reading frame encodes a conserved herpesvirus capsid/tegument-associated virion protein that is expressed with true late kinetics. J. Virol. 70:1996;3339-3345
56. Yurochko A.D., Kowalik T.F., Huong S.-M., Huang E.-S. Human cytomegalovirus upregulates NF-κB activity by transactivating the NF-κB p105/p50 and p65 promoters. J. Virol. 69:1995;5391-5400
57. Yurochko A.D., Mayo M.W., Poma E.E., Baldwin A.S. Jr., Huang E.-S. Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-κB promoters. J. Virol. 71:1997a;4638-4648
58. Yurochko A.D., Hwang E.S., Rasmussen L., Keay S., Periera L., Huang E.-S. The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-κB during infection. J. Virol. 71:1997b;5051-5059
59. Yurochko A.D., Huang E.-S. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol. 162:1999;4806-4816
60. Zhu H., Cong J.-P., Yu D., Bresnahan W., Shenk T.E. Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3932-3937